Entity Addresses, Address Type [Axis]
Business Contact [Member]
Related and Nonrelated Parties [Axis]
Nonrelated Party [Member]
Related Party [Member]
Sale of Stock [Axis]
Reverse Stock Split [Member]
Equity Components [Axis]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Investment, Name [Axis]
Sarborg Limited [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Equity Purchase Agreement [Member]
ELOC Second Amendment [Member]
Sale and Purchase Agreement [Member]
Pre-funded Warrants [Member]
Debt Instrument [Axis]
August Two Thousand Twenty Four Note [Member]
AGP Convertible Note [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
JJ Ascent Note [Member]
Fair Value, Inputs, Level 1 [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Derivative Instrument [Axis]
Cash and Cash Equivalents [Member]
Fair Value, Inputs, Level 2 [Member]
Convertible Notes Payable [Member]
Warrant [Member]
Short-Term Debt, Type [Axis]
Convertible Promissory Note [Member]
Ascent Note [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Measurement Input, Expected Term [Member]
Corporate Bond Yield Estimated Timing of Conversion [Member]
Measurement Input, Credit Spread [Member]
Measurement Input Probability of Default [Member]
Measurement Input Recovery Upon Default [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Exercise Price [Member]
Measurement Input, Risk Free Interest Rate [Member]
JJ Astor Note [Member]
Market Yield Estimated Timing Of Conversion Member Share Price [Member]
Convertible Promissory Notes Payable [Member]
2023 Convertible Note [Member]
Convertible Promissory Note Payable [Member]
Consulting Agreement [Member]
Senior Secured Promissory Note [Member]
Legal Entity [Axis]
Nirland Limited [Member]
First Amendment [Member]
Second Amendment [Member]
Convertible Promissory Notes [Member]
Alliance Global Partners [Member]
Alliance Gobal Partners Convertible Note [Member]
Convertible Note Binomial Lattice Model [Member]
Senior Secured Promissory Note With JJ Astor [Member]
Award Type [Axis]
Twenty Four Equal Weekly Installments [Member]
Second Amendment To JJ Astor Convertible Note [Member]
July 17, 2026 [Member]
July Twenty Four Two Thousand Twenty Six [Member]
July 31, 2026 [Member]
Three Scheduled Weekly Installment Payments [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Twenty Three Weekly Installment Payments [Member]
Third Amendment To JJ Astor Convertible Note [Member]
Loans Amendment [Member]
October 2024 Nirland Note [Member]
Class of Warrant or Right [Axis]
PIPE Warrants [Member]
Bridge Loan Agreement [Member]
Astra Zeneca [Member]
SARBORG Service Agreement [Member]
Service Agreement [Member]
SARBORG Additional Agreement [Member]
SARBORG Additional Service Agreement [Member]
Manoira Joint Development Agreement [Member]
Second Additional Agreement [Member]
Plan Name [Axis]
2023 Stock Incentive Plan [Member]
Title and Position [Axis]
Director [Member]
Crypto Consulting Agreement [Member]
Chief Executive Officer [Member]
Chief Financial Officer [Member]
Management [Member]
Restricted Stock Units (RSUs) [Member]
Three Board Members [Member]
Three Board Member [Member]
2023 Plan [Member]
Income Tax Jurisdiction [Axis]
Income Tax Jurisdiction, Domestic Federal [Member]
Income Tax Jurisdiction, Foreign [Member]
Income Tax Jurisdiction, Domestic State and Local [Member]
Tax Period [Axis]
Expiry Twenty Twenty Four [Member]
Indefinite Period [Member]
UNITED KINGDOM
Sales Agreement [Member]
Investment Objective [Axis]
Investor [Member]
Antidilutive Securities [Axis]
Public Warrants [Member]
A.G.P. Warrants [Member]
Equity Option [Member]
August 2024 Nirland Note [Member]
March 2024 Warrants [Member]
April 2024 Warrants [Member]
AGP 2024 Warrants [Member]
Lease Agreement [Member]
Corvus Capital Limited [Member]
Board of Directors [Member]
SARBORG Ltd [Member]
SARBORG Services Agreement [Member]
Joint Development Agreement [Member]
Related Party Transaction [Axis]
Officers and Directors [Member]
Private Placement [Member]
IPO [Member]
Public Warrant [Member]
Private Placement Warrant [Member]
March Lock Up Agreement [Member]
April Lock Up Agreement [Member]
Purchase Agreement Corvus [Member]
Pre Funded Warrant [Member]
Business Combination [Axis]
Murphy Canyon Acquisition Corp [Member]
Subscription Agreements [Member]
Segments [Axis]
Clinical Asset Development [Member]
Related Parties [Member]
Related Parties Digital Assets [Member]
Legal and Professional Fees [Member]
Litigation Liability Accrual [Member]
Accounting And Audit Fees [Member]
Salaries Payroll and Stock Based Compensation [Member]
Issuance of Common Stock and Pre-funded Warrants [Member]
Other [Member]
Securities Purchase Agreement [Member]
Variation Agreement [Member]
NJS Foresight Bio Advisory [Member]
Thesprogen [Member]
Amendment To Letter Agreement [Member]
Maxim Group LLC [Member]
Ex Animo Ltd [Member]
Entity Addresses [Table]
Entity Addresses [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Contact Personnel Name
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
ASSETS
Current assets
Cash and cash equivalents
Prepaid R&D services- related party (see Note 8 and Note 13)
Prepaid R&D services
Prepaid expenses and other current assets
Total current assets
Equity method investments
Operating lease right-of-use assets, net
Equipment and clinical assets, net
Prepaid expenses and other long-term assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable
Investment payable
Accrued expenses and other current liabilities
Accrued litigation liability
Operating lease liability, current portion
Convertible promissory note payable
Convertible promissory notes payable at fair value
Notes payable
Total current liabilities
Operating lease liability, non-current portion
Derivative warrant liability
Total liabilities
Commitments and contingencies (see Note 15)
Stockholders’ equity (deficit)
Common stock, par value $0.0001; 250,000,000 shares authorized at June 30, 2026 and December 31, 2025, 631,080 shares and 9,214 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Preferred stock, par value $0.0001; 1,000,000 shares authorized at June 30, 2026 and December 31, 2025; nil shares issued and outstanding at June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Income Statement [Abstract]
Operating expenses:
Research and development expenses
General and administrative expenses
Total operating expenses
Operating loss
Other income (expense):
Other expense, net
Loss on equity method investment
Interest income
Interest expense
Total other expense, net
Net loss
Diluted net loss per share
Basic net loss per share
Diluted weighted-average common shares outstanding
Basic weighted-average common shares outstanding
Comprehensive loss:
Foreign currency translation adjustment
Total comprehensive loss
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Correction of immaterial error related to franchise tax expense
Issuance of common stock for services
Issuance of common stock for services, shares
Issuance of Common Stock upon vesting of restricted stock units
Issuance of Common Stock upon vesting of restricted stock units, shares
Issuance of Common Stock for note payable
Issuance of Common Stock for note payable, shares
Issuance of Common Stock for licensing right
Issuance of Common Stock for licensing right, shares
Issuance of common stock under the ATM Program
Issuance of common stock under the ATM Program, shares
Issuance of Common Stock in Exchange for Debt Modification
Issuance of Common Stock in Exchange for Debt Modification, shares
Issuance of common stock upon exercise of conversion option
Issuance of common stock upon exercise of conversion option, shares
Issuance of warrants upon investment
Issuance of Common Stock Upon Exercise of Warrants
Issuance of Common Stock Upon Exercise of Warrants, shares
Stock-based compensation
Issuance of Common Stock Upon Exercise of Warrants, shares
Foreign currency translation adjustment
Net loss
Stock-based compensation
Stock-based compensation, shares
Share repurchases
Share cancellation
Share cancellation, shares
Issuance of common stock upon the sale of subsidiary
Issuance of common stock upon the sale of subsidiary
Issuance of warrants upon the sale of subsidiary
Shares issued for equity line of credit
Shares issued for equity line of credit, shares
Issuance of common stock upon investment
Issuance of common stock upon investment, shares
Exercise of warrants attributable to investment
Exercise of warrants attributable to investment, shares
Exercise of warrants attributable to the sale of previously controlled subsidiary
Exercise of warrants attributable to the sale of preciously controlled subsidiary, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Compensation expense recognized for the issuance of shares and warrants in connection with the sale of a previously controlled subsidiary
Gain on debt extinguishment, net
Loss on debt extinguishment, net
Realized gain on short-term investments
Loss on equity method investment
Gain on waiver of accrued interest
Unrealized foreign exchange (gain) loss
Loss (gain) on change in fair value of convertible notes payable
Gain on change in fair value of derivative warrant liability
Loss on issuance of warrants
Non-cash lease expense
Stock-based compensation expense
Issuance of common stock for licensing right
Non-cash interest expense
Depreciation expense
Amortization of financed directors and officers insurance
Amortization expense
Issuance of common stock for services
Issuance of common stock for services - related party
Amortization expense
Gain (loss) on issuance of common stock for services
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable
Accrued expenses and other liabilities
Accrued litigation liability
Lease liability
Net cash flows used in operating activities
Cash flows from investing activities:
Purchase of digital assets
Proceeds from disposal of digital assets
Purchases of equipment and clinical assets
Purchases of short-term investments
Proceeds from the sale of short-term investments
Net cash flows used in investing activities
Cash flows from financing activities:
Net proceeds from the issuance of notes payable
Proceeds from issuance of common shares related to the ATM program
Exercise of warrants
Repayment of notes payable
Proceeds from issuance of warrants
Repayment of notes payable – related parties
Repayment of convertible notes payable – related parties
Repayment of convertible notes payable
Purchases of treasury stock
Net cash flows provided by financing activities
Net change in cash and cash equivalents before effect of exchange rate changes
Effect of exchange rate changes on cash and cash equivalents
Net change in cash
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Right of Use Asset obtained in exchange for Operating Lease Liabilities
Correction of immaterial error related to franchise tax expense
Issuance of Common Stock upon exercise of conversion option
Issuance of Common Stock in exchange for debt extension
Shares cancelled
Conversion of deferred commission payable to convertible promissory note
Supplemental cash flow information:
Cash paid for interest
Loss (gain) on debt extinguishment, net
Change in fair value of convertible notes payable
Purchases of treasury stock
Cash paid for taxes
Non-cash investing and financing activities
Issuance of common stock upon exercise of conversion option
Issuance of common stock for services
Issuance of common stock for investment in related party
Deferred cash payable for investment in related party
Issuance of pre-funded warrants for investment in related party
Issuance of warrants upon the issuance of convertible note
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of the Business
Liquidity And Going Concern
Liquidity and Going Concern
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies
Sale Of Wholly-owned Subsidiary
Sale of Wholly-Owned Subsidiary
Fair Value Disclosures [Abstract]
Fair Value
Digital Assets
Digital Assets
Leases
Leases
Convertible Notes Payable
Convertible Notes Payable
Debt Disclosure [Abstract]
Loans Payable
Research And Development Expense
Research and Development Expense
Share-Based Payment Arrangement [Abstract]
Share Based Compensation
Income Tax Disclosure [Abstract]
Income Taxes
Equity [Abstract]
Common Stock and Preferred Stock
Earnings Per Share [Abstract]
Net Loss Per Share
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Related Party Transactions [Abstract]
Related Party Transactions
Other Income and Expenses [Abstract]
Other Expense, net
Warrants
Warrants
Segment Reporting [Abstract]
Segments
Subsequent Events [Abstract]
Subsequent Events
Equity Method Investments and Joint Ventures [Abstract]
Investments
Balance Sheet Details
Basis of Presentation
Principles of Consolidation
Reclassification
Other Risks and Uncertainties
Use of Estimates
Cash and Cash Equivalents
Fair Value Measurements
Fair Value Option
Equipment and Clinical Assets
Leases
Research and Development
Purchased Research and Development Assets
Income Taxes
Net Loss per Share Attributable to Common Stockholders
Warrants
Stock-based Compensation
Foreign Currency Translation
Emerging Growth Company Status [Policy Text Block]
Recently Issued Accounting Standards Adopted
Recently Issued Accounting Standards Not Yet Adopted
Investments
ELOC
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Schedule of Assets Subject to Measurement at Fair Value on Recurring Basis
Schedule of Additional Information About the Financial Liabilities Subject To Measurement at Fair Value
Schedule of Fair Value of Assumptions
Schedule of Investments Digital Assets
Schedule of Lease Cost
Schedule of Operating Lease Liabilities
Schedule of Future Minimum Lease Payments For Operating Lease
Schedule of Restricted Stock Activity
Schedule of Fair Value of Stock Option Granted
Schedule of Stock Option Activity
Schedule of Income before Income Tax, Domestic and Foreign
Schedule of Provision for Income Tax
Schedule of Unrecognized Tax Benefits
Schedule of Income Taxes Net of Refunds
Schedule of Effective Income Tax Rate Reconciliation
Schedule of Deferred Tax Assets and Liabilities
Schedule of Basic and Diluted Net Loss Per Share
Schedule of Potentially Dilutive Securities
Schedule of Other Expense, Net
Schedule of Black-Scholes Option Pricing Model
Schedule of Financial Data for the Company’s Reportable Segment
Schedule of Investment in Sarborg Using Cost Method
Summary of Financial Information for Sarborg
Schedule of Balance Sheet Details
Schedule of Accrued Expenses and Other Current Liabilities
Subsequent Event [Table]
Subsequent Event [Line Items]
Stockholders' Equity, Reverse Stock Split
Accumulated deficit
Cash and cash equivalents
Net operating losses
Operating activities
Cash provided by operating activities
Proceeds from market offering program
AccountingPoliciesTable [Table]
Prepaid expense
Cash, uninsured amount
Deposit assets
Demand deposit accounts
Deposit insurance limit
Cash and cash equivalents
Cash and cash equivalents net bank overdrafts
Equity Method Investment, Description of Principal Activities
Issuance common stock
Common stock, voting rights
Share price
Minimum price per share
Gross purchase price to be paid
Sale of stock
Stock proceeds
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Warrants issued, sahres
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding
[custom:PlaintiffForCashAdvisoryFees]
Loss Contingency, Damages Sought, Value
[custom:LegalCostReimbursement]
[custom:LegalCostReimbursementTotal]
[custom:AccruedLitigationLiability-0]
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)
Share Price
Stock Issued During Period, Value, New Issues
Warrants issued, value
Issuance of shares and warrants
Total Assets
Total Liabilities
Balance as of December 31, 2025
Fair value at issuance
Conversion of convertible notes
Change in fair value
Interest expense
Cash repayment
Gain on settlement of convertible note
Balance as of June 30, 2026
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input
Measurement input term
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Principal amount
Repayment outstanding value
Net proceeds
Schedule Of Investments Digital Assets
Balance as of December 31, 2024
Purchases
Dispositions
Realized losses on dispositions
Balance as of December 31, 2025
Schedule Of Lease Cost
Operating lease cost
Short-term lease cost
Variable lease cost
Total lease cost
Schedule Of Operating Lease Liabilities
Operating cash flows from operating leases
ROU assets obtained in exchange for lease liabilities
Weighted-average remaining lease term (in years)
Weighted-average discount rate
2026
Total
Less: imputed interest
Total lease liability
Right of use asset
Short term lease liability
Long-term lease liability
DisclosureConvertibleNotesPayableTable [Table]
Debt principal amount
Maturity date
Interest rate
Settlement of debt
Gain on debt extinguishment
Convertible promissory notes payable
Interest expense
Debt Instrument, Unamortized Discount
Convertible notes payable
Carrying value
Par value
Convertible debt
Gain loss on change in fair value
Accured interest
Amortization expenses
Amortization of debt discount
Gain on change in fair value
Debt conversion, converted instrument, amount
Conversion of shares
Interest Payable, Current
Notes Payable, Fair Value Disclosure
Proceeds from Fees Received
Common Stock an exercise price
Payments for Other Fees
[custom:DeferredCommissionPayableAnnualInterestRate-0]
Accrued Liabilities
Other Income
Interest Expense, Operating and Nonoperating
Conversion percentage
Shares Issued, Price Per Share
Debt Instrument, Convertible, Conversion Price
Fair value of convertible note
Deferred commission payable
Fair value of convertible note
Gain on change in fair value of convertible note
Common stock shares outstanding
Convertible note
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Loss on conversion amount
Debt valuation amount
Proceeds from convertible note
Repayments of debt
Note payable to periodic payment
Common stock purchase warrants
Interest rate
Bridge loan
Debt Instrument, Maturity Date
Cash
Stock Issued During Period, Value, Conversion of Units
Stock Issued During Period, Shares, Conversion of Units
Arrangement fee percentage
Class of Warrant or Right, Exercise Price of Warrants or Rights
Proceeds from Warrant Exercises
Repayment of principal and interest amount
Debt obligations amount
Interest expense
Commitment fees
Class of Warrant or Right, Outstanding
Common Stock, Par or Stated Value Per Share
Common stock closing price percentage
Fair Value Adjustment of Warrants
Warrants and Rights Outstanding
Notes Payable
ResearchAndDevelopmentExpenseTable [Table]
Proceeds from Issuance of Common Stock
Shares issued
General and Administrative Expense
Research and Development Expense
Cash payment
Repayments of Other Debt
Amortization
Prepaid Expense
Intangible assets current
Agreement related expense
Diagnostic asset
Fair value of asset acquired
Issuance of common stock services
Remaining debt
Equity consideration received per transaction
Payment of Financing and Stock Issuance Costs
Other Intangible Assets, Net
Payable in cash
Consideration payable
Number of Awards, Outstanding
Weighted Average Grant Date Fair Value, Outstanding
Number of Awards, Granted
Weighted Average Grant Date Fair Value, Granted
Number of Awards, Cancelled/Forfeited
Weighted Average Grant Date Fair Value, Cancelled/Forfeited
Number of Awards, Vested
Weighted Average Grant Date Fair Value, Vested
Number of Awards, Outstanding
Weighted Average Grant Date Fair Value, Outstanding
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected Volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Expected dividend yield
Number of Options, Outstanding
Weighted Average Exercise Price, Outstanding
Weighted Average Remaining Contractual Term Years
Aggregate Intrinsic Value
Number of Options, Granted
Weighted Average Exercise Price, Granted
Number of Options, Cancelled/forfeited
Weighted Average Exercise Price, Cancelled/Forfeited
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Outstanding
Weighted Average Exercise Price, Outstanding
Weighted Average Remaining Contractual Term Years
Aggregate Intrinsic Value
Number of Options, Exercisable
Weighted Average Exercise Price, Exercisable
Weighted Average Remaining Contractual Term Years
Aggregate Intrinsic Value
Number of Options, Unvested
Weighted Average Exercise Price, Unvested
Weighted Average Remaining Contractual Term Years
Aggregate Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum
Number of authorized shares
Other expenses
Shares granted
Share-Based Payment Arrangement, Expense
Prepaid Expense, Current
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Stock Issued During Period, Value, Restricted Stock Award, Gross
[custom:WeightedaverageGrantdateFairValueOfOptionsGranted]
Cost related to non-vested option
Weighted average remaining vesting
Stock-based compensation expense recognized
Loss from operations before income taxes:
US
Foreign
Loss from operations before income taxes
Federal
State
Foreign
Current income tax
Federal
State
Foreign
Deferred income tax
Net Income Tax Expense
Unrecognized tax benefits, beginning of period
Increases (decreases) for prior year tax positions
Decreases for expiration of statute of limitations
Settlements
Unrecognized tax benefits, end of period
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Federal
Foreign
Total
Taxes at federal statutory rate
Taxes at federal statutory rate, percent
State income tax, net of federal benefit
State income tax, net of federal benefit, percent
NOL adjustment
NOL adjustment, percent
Change in valuation allowance
Change in valuation allowance, percent
Other
Other, percent
Foreign Rate Differential
Foreign rate differential, rate
Non-deductible loss on stock issuance
Non-deductible loss on stock issuance, percent
Convertible debt
Convertible debt, percent
Other permanent items
Other permanent items, percent
Other
State Re-Rate
State re-rate, percent
Total provision (benefit) for income taxes
Total provision (benefit) for income taxes, percent
Stock options
Transaction Costs
Research & Development
Accruals
Net operating loss carryforward
Valuation allowance
Net deferred income tax asset
Total deferred tax liabilities
Net deferred income tax liability
U S Federal statutory income tax rate, percentage
Net operating loss
Effective income tax rate reconciliation future income years tax rate
Deferred tax assets valuation allowance
Non deductable loss
Consolidated pre tax loss percentage
Income tax holiday description
Effective tax rate
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Dividends, Cash
Sale of stock consideration
Sale of stock, percentage
Sale of Stock, Number of Shares Issued in Transaction
Payments of Stock Issuance Costs
Equity Method Investment, Ownership Percentage
[custom:StockIssuedDuringPeriodSharesIssuanceOfCommonStockUponInvestmentShares]
[custom:StockIssuedDuringPeriodValueIssuanceOfCommonStockUponInvestment]
Warrants exercise price
Warrants issued, shares
Cashless exercise, shares
Net loss - basic
Net loss - diluted
Weighted Average Number of Shares Outstanding, Diluted
Net loss per share, basic
Net loss per share, diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Loss Contingencies [Table]
Litigation Settlement, Fee Expense
[custom:BusinessCombinationCommonStockOnMarketValueStand]
[custom:InterestAndRepaymentOnStrandsCosts]
[custom:StrandsCosts]
Ltigation liability
Area of land
Operating lease right of use asset
Operating lease liability
Short-term lease liability
Future minimum lease payments remaining
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Common share subscription
Travel expenses payable
Research and development expense
Prepaid expense
Sale of Stock, Price Per Share
Sale of Stock, Consideration Received Per Transaction
Payments for fees
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Fair Value of Assets Acquired
Change in fair value of warrant liability
Change in fair value of convertible note payment
Gain on debt extinguishment
Income Tax Refund
Unrealized foreign currency transaction gain
Gain on waiver of accrued interest
Research and development tax receivable
Gain on the issuance of shares for services
Other
Total other income:
Loss on debt extinguishment
Loss on the change in fair value of convertible notes payable
Realized losses on disposition of digital assets
Realized foreign currency transaction loss
Other expense
Total other expense
Total expense, net
Gain on change in fair value of derivative warrant liability
Gain on change in fair value of convertible notes payable
Interest income
Interest expense
Loss on equity method investment
Other
Total other expense
Schedule Of Black-scholes Option Pricing Model
Closing stock price
Contractual exercise price
Risk-free rate
Estimated volatility
Time period to expiration
DisclosureWarrantsTable [Table]
DisclosureWarrantsLineItems [Line Items]
Issuance warrants
Additional Paid in Capital
Gain (Loss) on Investments
Warrant purchase
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Fair value option changes
Warrant liability
Segment Reporting [Table]
Segment Reporting [Line Items]
General and administrative expenses
Total operating costs and expenses
Other income (expenses):
Other expense
Other expense – digital assets
Interest expense, net
Loss on investment
Operating segment
[custom:MinimumPricePerShare-0]
Total principal amount
Annual rate interest, percentage
Warrants to purchase shares
Pre-funded warrants shares
Facility Costs
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Debt Conversion, Converted Instrument, Amount
Debt Conversion, Converted Instrument, Shares Issued
Consideration for entering addendum description
Debt principal amount
Number of shares acquire from investors
Acquired percentage
Stock issued for services
Shares issued for services
Number of shares issued
Balance as of December 31, 2025
Investment in Sarborg
Loss on equity investment in Sarborg
Impairment on equity investment in Sarborg
Balance as of June 30, 2026
Current assets
Non-current assets
Current liabilities
Non-current liabilities
Net assets
Company share of net assets
Revenue
Company share of net loss
Equity Method Investment [Table]
Schedule of Equity Method Investments [Line Items]
Equity interest percent
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Value
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares
Cash payable
Increase (Decrease) in Partners' Capital
Recognized loss on investment
Equity method investments, carrying value
Prepaid expenses
Tax receivable
Prepaid directors’ and officers’ insurance
Total prepaid expenses and other current assets
Accrued professional fees
Accrued legal contingency
HMRC payable
Accrued board of directors’ fees, year to date
Accrued other
Total accrued expenses and other current liabilities
Prepaid rd services related party
Prepaid rd services.
Adjustments to additional paid in capital correction of immaterial error related to franchise tax expense.
Issuance of common stock for note payable.
Issuance of common stock for note payable, shares.
Stock issued during period value issuance of common stock.
StockIssuedDuringPeriodSharesIssuanceOfCommonStock
Stock issued during period value issuance of common stock in exchange for debt modification.
Stock issued during period shares issuance of common stock in exchange for debt modification.
Stocki ssued during period value issuance of common stock upon exercise of conversion option
Stock issued during period shares issuance of common stock upon exercise of conversion option.
Stock issued during period value issuance of common stock upon exercise of warrants.
Stock issued during period shares issuance of common stock upon exercise of warrants.
Stock issued during period value issuance of common stock upon sale of subsidiary.
Stock issued during period shares issuance of common stock upon sale of subsidiary.
Adjustments to additional paid in capital issuance of warrants upon sale of subsidiary.
Gains on waiver of accrued interest.
Gain on debt extinguishment net.
Loss on deconsolidation of previously controlled subsidiary.
Realized gain on shortterm investments.
Loss gain on change in fair value of convertible notes payable.
Loss on issuance of warrants.
Noncash lease expense.
Non-cash interest expense.
Depreciation expense.
Amortization of debt issuance costs.
Issuance of common stock for licensing right.
Amortization of debt discount.
Increase decrease in accrued expenses and other current liabilities.
Repayment of notes payable related parties.
Repayment of convertible notes payable - related parties.
Proceeds from exercise of warrants.
Correction of immaterial error related to franchise tax expense.
Issuance of common stock in exchange for debt extension.
Issuance of common stock for services.
Cancellation of shares.
Conversion of deferred commission payable to convertible promissory note.
Deposit insurance limit.
Cash and cash equivalents net bank overdrafts.
Equipment and Clinical Assets [Policy Text Block]
Warrant Instruments [Policy Text Block]
Stock Options [Policy Text Block]
Emerging Growth Company Status [Policy Text Block]
New Accounting Pronouncements Not Yet Adopted [Policy Policy Text Block]
Sale and Purchase Agreement [Member]
Pre-funded Warrants [Member]
Change in fair value of convertible notes payable.
AGP Convertible Note [Member]
Corporate Bond Yield Estimated Timing of Conversion [Member]
Measurement Input Probability of Default [Member]
Measurement Input Recovery Upon Default [Member]
Digital Assets [Disclosure Text Block]
Lessee Operating Lease Liability [Table Text Block]
Corvus Capital Limited [Member]
Purchase of equipment and clinical assets.
Convertible Notes Payable [Text Block]
Convertible Promissory Notes Payable [Member]
Convertible Promissory Note [Member]
2023 Convertible Note [Member]
Convertible Promissory Note Payable [Member]
Consulting Agreement [Member]
Senior Secured Promissory Note [Member]
Nirland Limited [Member]
Convertible Promissory Notes [Member]
Alliance Global Partners [Member]
Deferred commission payable annual interest rate.
Alliance Gobal Partners Convertible Note [Member]
Deferred commission payable
Gain on change in fair value
Gain on change in fair value of convertible note
Gain loss on conversion amount.
Loans Amendment [Member]
October 2024 Nirland Note [Member]
Arrangement fee percentage.
PIPE Warrants [Member]
Commitment fees.
Bridge Loan Agreement [Member]
Common stock closing price percentage.
Disclosure Of Research And Development License Agreement [Text Block]
Astra Zeneca [Member]
Payment to research and devolpment amount.
Sarborg Service Agreement [Member]
Service Agreement [Member]
Diagnostic asset.
SARBORG Additional Agreement [Member]
SARBORG Additional Service Agreement [Member]
Sarborg Limited [Member]
Equity consideration received per transaction.
Manoira Joint Development Agreement [Member]
Two Thousand Twenty Three Plan [Member]
Share based compensation arrangement by share based payment award options unvested outstanding number.
Share based compensation arrangement by dhare based payment award options vested and expected to unvested outstanding weighted average exercise price.
Share based compensation arrangement by share based payment unvested award vesting period 1.
Sharebased compensation arrangement by sharebased payment Award options unvested intrinsic value 1.
2023 Stock Incentive Plan [Member]
Crypto Consulting Agreement [Member]
Three Board Member [Member]
Three Board Members [Member]
Deferred tax assets stock options.
Effective income tax rate reconciliation future income years tax rate.
Effective income tax rate reconciliation foreign tax effects other.
Income tax reconciliation nondeductible expense loss on stockissuance.
Income tax reconciliation nondeductible expense convertible debt.
Effective income tax rate non deductible loss on stockissuance.
Effective income tax rate nondeductible convertible debt.
Indefinite Period [Member]
Expiry Twenty Twenty Four [Member]
Convertible Note Binomial Lattice Model [Member]
Sales Agreement [Member]
Board of Directors [Member]
SARBORG Ltd [Member]
SARBORG Services Agreement [Member]
Joint Development Agreement [Member]
Officers and Directors [Member]
Change in fair value of warrant liability.
Change in fair value of convertible note payment.
Gain on debt extinguishment.
Income tax refund.
Gain on waiver of accrued interest.
Research and development tax receivable.
Gain on issuance of shares for services.
Loss on debt extinguishment.
Other expense change in fair value of convertible notes payable.
Loss on conversion of convertible notes payable.
Warrant Liability Disclosure [Text Block]
Public Warrant [Member]
Private Placement Warrant [Member]
March Lock Up Agreement [Member]
Schedule of Share Based Payment Award Stock Purchase Warrants Valuation Assumptions [Table Text Block]
April Lock Up Agreement [Member]
April 2024 Warrants [Member]
March 2024 Warrants [Member]
AGP 2024 Warrants [Member]
Murphy Canyon Acquisition Corp [Member]
Subscription Agreements [Member]
Equity Purchase Agreement [Member]
Securities Purchase Agreement [Member]
Purchase Agreement Corvus [Member]
Second Additional Agreement [Member]
Stock cancellation suring period value.
Stock cancellation during period shares
Public Warrants [Member]
A.G.P. Warrants [Member]
August 2024 Nirland Note [Member]
Clinical Asset Development [Member]
Related Parties Digital Assets [Member]
Legal and Professional Fees [Member]
Accounting and Audit Fees [Member]
Salaries Payroll and Stock Based Compensation [Member]
Other [Member]
Related Parties [Member]
Pre Funded Warrant [Member]
Other Risks And Uncertainties [Policy Text Block]
August Two Thousand Twenty Four Note [Member]
First Amendment [Member]
Second Amendment [Member]
Income Tax Paid By Individual Jurisdiction [Table Text Block]
Income tax reconciliation nondeductible expense state rerate.
Effective income tax rate reconciliation foreign tax effects state rerate.
Other expense digital assets.
Realized losses on disposition of digital assets.
Gain on settlement of convertible note.
Weighted average grant date fair value of the options granted.
Other expense.
Liquidity And Going Concern [Text Block]
Compensation expense recognized for issuance of shares and warrants in connection with sale of previously controlled subsidiary.
Loss on debt extinguishment net.
Sales Of Wholly Owned Subsidiary Disclosure [Text Block]
Rou assets obtained in exchange for lease liabilities.
Consolidated pre tax percentage.
Issuance of Common Stock and Pre-funded Warrants [Member]
General and administrative expenses.
Accrued litigation liability
Loss on disposal of crypto holdings
Increase decrease in accrued litigation liability
Plaintiff for cash advisory fees
Legal cost reimbursement
Legal cost reimbursement total
Business combination common stock on market value stand
Litigation Liability Accrual [Member]
Consideration for entering addendum description
Interest and repayment on strands costs.
Minimum price per share.
Strands costs.
Gain (loss) on issuance of common stock for services.
Issuance of common stock for services - related party
Stock issued during period value for equity line of credit.
Stock issued during period shares for equity line of credit.
Stock issued during period value issuance of common stock upon investment.
Stock issued during period shares issuance of common stock upon investment shares.
Stock issued during period value exercise of warrants attributable to investment.
Exercise of warrants attributable to the sale of previously controlled subsidiary, shares
Stock issued during period shares exercise of warrants attributable to investment shares.
Exercise of warrants attributable to the sale of previously controlled subsidiary.
Change in fair value of convertible notes payable.
Purchases of treasury stock.
Issuance of common stock upon exercise of conversion option.
Issuance of common stock for investment in related party.
Deferred cash payable for investment in related party.
Issuance of pre-funded warrants for investment in related party.
Issuance of warrants upon issuance of convertible note.
Proceeds from market offering program.
Equity Line of Credit Facility [Policy Text Block]
Net assets.
Company share of net liabilities.
Company share of net loss.
Accrued contingency
Investment payable current.
Accrued directors fees.
Cash payment.
Gain on change in fair value of convertible notes payable.
Other interest expense.
Loss on equity method investment.
Expenses other.
Loss on equity method investment.
Other nonoperating income expenses.
Reverse Stock Split [Member]
Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term.
ELOC Second Amendment [Member]
JJ Ascent Note [Member]
Ascent Note [Member]
Market Yield Estimated Timing Of Conversion Member Share Price [Member]
JJ Astor Note [Member]
Senior Secured Promissory Note With JJ Astor [Member]
Twenty Four Equal Weekly Installments [Member]
Second Amendment To JJ Astor Convertible Note [Member]
July 17, 2026 [Member]
July 31, 2026 [Member]
Three Scheduled Weekly Installment Payments [Member]
Twenty Three Weekly Installment Payments [Member]
Third Amendment To JJ Astor Convertible Note [Member]
Lease Agreement [Member]
Variation Agreement [Member]
Thesprogen [Member]
NJS Foresight Bio Advisory [Member]
Amendment To Letter Agreement [Member]
Maxim Group LLC [Member]
Ex Animo Ltd [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Income (Loss)
Other Nonoperating Expense
Nonoperating Income (Expense)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture
Stock Repurchased During Period, Value
Stock cancellation suring period value
Stock cancellation during period shares
StockIssuedDuringPeriodSharesIssuanceOfCommonStockUponSaleOfSubsidiary
GainOnDebtExtinguishmentNet
RealizedGainOnShorttermInvestments
LossOnDisposalOfCryptoHoldings
Unrealized Gain (Loss), Foreign Currency Transaction, after Tax
LossGainOnChangeInFairValueOfConvertibleNotesPayable
Issuance of Stock and Warrants for Services or Claims
AmortizationOfDebtDiscount
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
IncreaseDecreaseInAccruedLitigationLiability
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payment for Acquisition, Crypto Asset
PurchaseOfEquipmentAndClinicalAssets
Payments to Acquire Short-Term Investments
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Notes Payable
RepaymentOfNotesPayableRelatedParties
RepaymentOfConvertibleNotesPayableRelatedParties
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
CorrectionOfImmaterialErrorRelatedToFranchiseTaxExpense
PurchasesOfTreasuryStock
IssuanceOfCommonStockUponExerciseOfConversionOption
IssuanceOfCommonStockForServices
Digital Assets [Disclosure Text Block]
Lessee, Operating Leases [Text Block]
Convertible Notes Payable [Text Block]
Warrant Liability Disclosure [Text Block]
Lessee, Leases [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Warrant Instruments [Policy Text Block]
Equity Method Investments [Policy Text Block]
Cash, Cash Equivalents, and Short-Term Investments
Cash Equivalents, at Carrying Value
Debt Instrument, Convertible, Beneficial Conversion Feature
Crypto Asset, Fair Value
Crypto Asset, Disposition
Lease, Cost
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Interest Expense, Debt
Debt Instrument, Fair Value Disclosure
Debt Instrument, Interest Rate During Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToUnvestedOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentUnvestedAwardVestingPeriod1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedIntrinsicValue1
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Current Foreign Tax Expense (Benefit)
Deferred Federal Income Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Deferred Foreign Income Tax Expense (Benefit)
Unrecognized Tax Benefits
Income Tax Paid, Federal, after Refund Received
Income Tax Paid, Foreign, after Refund Received
IncomeTaxReconciliationNondeductibleExpenseConvertibleDebt
IncomeTaxReconciliationNondeductibleExpenseStateRerate
Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Net
GainOnDebtExtinguishment
GainOnWaiverOfAccruedInterest
Other Nonoperating Income
OtherNonoperatingIncomeExpenses
Other Nonoperating Income (Expense)
Interest Income, Other
Other interest expense.
LossOnEquityMethodInvestments
ExpensesOther
GeneralAndAdministrativeExpenses
NetAssets
Accounts Payable and Other Accrued Liabilities, Current